All DUSA Pharmaceuticals articles

  • Whistleblower
    Article

    Mass. pharma company will pay $20.75M to settle FCA lawsuit

    2020-08-25T16:50:00Z

    A Massachusetts-based pharmaceutical company will pay $20.75 million settle a whistleblower’s allegations that the company knowingly promoted misleading instructions for a skin lesion drug that caused doctors to submit false claims to Medicare.